Causes, Not Just Cases® | The Motley Rice Law Blog

Filter By

Clear Filters

December 3, 2019

SEC whistleblower office reports another promising year, reaffirms commitment to whistleblower protection and enforcement actions

Eight years after its inception, the SEC’s Whistleblower Program continues to have a significant, positive impact in protecting not only whistleblowers, but investors, markets and by extension, the public. In addition, the Whistleblower Program allows the SEC to bring enforcement actions in considerably less time, using fewer resources.

Read More

November 12, 2019

Dangerous vehicle defects may put millions of Americans at risk

We put a lot of faith in auto manufacturers. As our vehicles become loaded with technological advancements, we have trust the manufacturers have installed these features to help protect us. We often assume that manufacturers tested and vetted this technology appropriately. And, we trust these features will actually work as intended and save us from harm during an accident. But are we too quick to make this assumption?

Read More

October 1, 2019

Asbestos is still a threat

As Mesothelioma Awareness Month comes to an end, I am often reminded that asbestos remains a constant threat. Take the news from just last month that several top aides were evacuated from the White House so that asbestos could be removed from the ceilings and attic spaces in the West Wing’s second floor. The U.S. General Services Administration described this as a mere “precautionary measure,” but I think that’s putting it mildly as asbestos is a dangerous, deadly carcinogen.

Read More

August 19, 2019

FDA’s push for transparency long overdue

Generally speaking, manufacturers are required to submit individual reports to the FDA for each patient who sustains an injury or complication caused by a medical product. Established in 1997, Alternative Summary Reporting Program allowed manufacturers to bypass that standard by submitting quarterly summaries for cases that involve “well-known” complications. The FDA claims that this policy allowed the agency to “more efficiently review reports of well-known, well-understood adverse events.” However, the public was largely kept in the dark because this massive database was kept hidden, available only to the FDA – until now.

Read More

July 30, 2019

Whistleblower Appreciation Day reinforces nation’s commitment to justice, accountability

July 30 is National Whistleblower Appreciation Day, commemorating the signing of our country’s first whistleblower law in 1778. In the midst of the Revolutionary War, and faced with the dilemma of how to address the retaliatory dismissal and jailing of a pair of Navy sailors who had reported the mistreatment of enemy soldiers, our country’s earliest leaders made the critical choice to stand by these whistleblowers.

Read More

July 1, 2019

Youth vaping/e-cig use on the rise as states, cities push for protections

Vaping among today’s youth has reached crisis levels. If you have any doubt, look at the numbers. Even as traditional cigarette use continues to decline among high school students, vaping “increased alarmingly” between 2017 and 2018 by 78 percent, according to the FDA, to more than 3 million American teens. Shockingly, when accounting for middle schoolers, that number rises to more than 3.6 million.

Read More

June 14, 2019

Innovative class action approach in opioid litigation would create a beneficial and coordinated negotiating class on behalf of communities nationwide

With the volume of filed National Prescription Opiate Litigation cases (more than 1,800), which comprise just 10% of the nation’s counties and cities, a structure and process is needed to provide all counties and cities nationwide, filed and unfiled, with a collective and powerful voice in the litigation, and create a pre-established mechanism through which plaintiffs can consider and have a vote in potential settlements with defendants.

Read More

January 30, 2019

An eye opening look at human trafficking

Fundamental human rights include personal freedom and the right to determine the fate of one’s own mind and body. Such rights are all too often stripped away from millions of people worldwide, including what statistics indicate to be countless innocent children.

Read More

January 28, 2019

Looking ahead: Top five litigations to watch in 2019

There are several areas of litigation worth keeping an eye on over the year ahead, with five in particular we’re working on that stand out to me in large part due to the urgent consumer and public health needs they hope to address. I’ve listed these five below, including my take on why they are noteworthy.

Read More